Cargando…
SIRT3 is attenuated in systemic sclerosis skin and lungs, and its pharmacologic activation mitigates organ fibrosis
Constitutive fibroblast activation is responsible for organ fibrosis in fibrotic disorders including systemic sclerosis (SSc), but the underlying mechanisms are not fully understood, and effective therapies are lacking. We investigated the expression of the mitochondrial deacetylase sirtuin 3 (SIRT3...
Autores principales: | Akamata, Kaname, Wei, Jun, Bhattacharyya, Mitra, Cheresh, Paul, Bonner, Michael Y., Arbiser, Jack L., Raparia, Kirtee, Gupta, Mahesh P., Kamp, David W., Varga, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342480/ https://www.ncbi.nlm.nih.gov/pubmed/27732568 http://dx.doi.org/10.18632/oncotarget.12504 |
Ejemplares similares
-
Honokiol, an activator of Sirtuin-3 (SIRT3) preserves mitochondria and protects the heart from doxorubicin-induced cardiomyopathy in mice
por: Pillai, Vinodkumar B., et al.
Publicado: (2017) -
Early Stage Lung Cancer Detection in Systemic Sclerosis Does Not Portend Survival Benefit: A Cross Sectional Study
por: Katzen, Jeremy B., et al.
Publicado: (2015) -
Tenascin-C drives persistence of organ fibrosis
por: Bhattacharyya, Swati, et al.
Publicado: (2016) -
Stromal Fibrosis of the Breast and the Associated Radiological Findings
por: Shroff, Neel K, et al.
Publicado: (2021) -
Honokiol blocks and reverses cardiac hypertrophy in mice by
activating mitochondrial SIRT3
por: Pillai, Vinodkumar B., et al.
Publicado: (2015)